Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
Lung Cancer Update
00:00
TDXD in Lung Cancer?
I do think her to expression is coming as a biomarker for lung cancer. The response rate was a lot lower than in her to mutant, but it was still probably about the same as you would see with dose of tax based therapies. And so I do think there's promise there needs to be studied in sort of larger groups. But I would probably stick with that 5.4 because I think the greater threat is really just not adequately treating the cancer.
Transcript
Play full episode
